MedPath

Risk and Resilience Factors in Learning Disabilities Population

Not Applicable
Conditions
Learning Disorders
Registration Number
NCT01652651
Lead Sponsor
Rabin Medical Center
Brief Summary

The purpose of this study is to report preliminary outcomes of executive function and psychopathology symptoms of a manual-based psychological intervention for adolescents diagnosed with learning disorders- I can succeed (ICS).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Learning Disorder diagnosis
  • Normal range IQ
  • Regular class attendance
Exclusion Criteria
  • Suicidal ideation and psychosis

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Change in Child Behavior Checklist (CBCL) (Achenbach, 1991).base line (time 0) and end of treatment (3 month)

The Child Behavior Checklist (CBCL) is a device by which parents and teachers rate a child's problem behaviors and competencies. It consists of 112 behavioral items (and 1 open-ended item) scored on a 3-step response scale from Not true (0) to Very true or Often true (2). Subscales include Aggressive Behavior, Anxious/Depressed, Attention Problems, Delinquent Rule-Breaking Behavior, Social Problems, Somatic Complaints, Thought Problems, Withdrawn, Externalizing, Internalizing, Total Problems, plus DSM-oriented scales.

Secondary Outcome Measures
NameTimeMethod
Change in The standardized Brain Resource cognition assessment, ''IntegNeuro,'' (Clark et al., 2006).base line (time 0) and end of treatment (3 month)

A computerized standardized assessment of Executive Functions and Continuous Performance Test

Trial Locations

Locations (1)

Schneider Children Medical Center of Israel

🇮🇱

Petah Tikva, Israel

Schneider Children Medical Center of Israel
🇮🇱Petah Tikva, Israel
Daphne Kopelman-Rubin, Ph.D
Contact
+972-9-9549497
Daphnekr@idc.ac.il

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.